NASDAQ : NXGL
NEXGEL, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 3.88 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.89M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.71M |
| Enterprise Value | 8.68M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 487,383 |
| Shares Outstanding | 487,383 |
| Shares Change (YoY) | +13.67% |
| Shares Change (QoQ) | +9.86% |
| Owned by Insiders (%) | 13.59% |
| Owned by Institutions (%) | 6.04% |
| Float | 383,885 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| Forward PS | 0.18 |
| PB Ratio | 0.34 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.43 |
| Quick Ratio | 0.11 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.39 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -115.07% |
| Return on Assets (ROA) | -18.67% |
| Return on Invested Capital (ROIC) | -32.73% |
| Return on Capital Employed (ROCE) | -44.99% |
| Weighted Average Cost of Capital (WACC) | 21.11% |
| Revenue Per Employee | $635,105 |
| Profits Per Employee | -$325,579 |
| Employee Count | 19 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 3.80 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.81 |
| 52-Week Price Change | -92.84% |
| 50-Day Moving Average | 5.14 |
| 200-Day Moving Average | 12.53 |
| Relative Strength Index (RSI) | 38.68 |
| Average Volume (20 Days) | 247,328 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 104,742 |
| Short Previous Month | 322,449 |
| Short % of Shares Out | 21.49% |
| Short % of Float | 27.28% |
| Short Ratio (days to cover) | 0.50 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 12.07M |
| Gross Profit | 4.23M |
| Operating Income | -5.40M |
| Pretax Income | -6.05M |
| Net Income | -6.19M |
| EBITDA | -4.25M |
| EBIT | -5.40M |
| Loss Per Share | -$15.00 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 492,000 |
| Total Debt | 7.46M |
| Net Cash | -6.97M |
| Net Cash Per Share | -$14.29 |
| Equity (Book Value) | 5.47M |
| Book Value Per Share | 10.20 |
| Working Capital | -8.27M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -3.21M |
| Capital Expenditures | -133,000 |
| Depreciation & Amortization | 1.15M |
| Net Borrowing | 10.04M |
| Free Cash Flow | -3.34M |
| FCF Per Share | -$6.85 |
Margins
| Measure | Value |
|---|
| Gross Margin | 35.08% |
| Operating Margin | -44.77% |
| Pretax Margin | -50.16% |
| Profit Margin | -51.26% |
| EBITDA Margin | -35.23% |
| EBIT Margin | -44.77% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -13.67% |
| Shareholder Yield | -13.67% |
| Earnings Yield | -427.44% |
| FCF Yield | -195.12% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 31.74% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 12, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.58 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |